HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up.

AbstractBACKGROUND & AIMS:
Data on the incidence and remission rates of non-alcoholic fatty liver disease (NAFLD) as well as predictive factors are scant. This study aims at evaluating NAFLD's epidemiology in prospective follow-up of individuals sampled from the general population.
METHODS:
Evaluation of metabolic parameters and ultrasonographic evidence of NAFLD was performed in 213 subjects, with no known liver disease or history of alcohol abuse. The evaluation was performed at baseline and after a 7-year period by identical protocols.
RESULTS:
Of the 147 patients who did not have NAFLD at baseline, 28 (19%) were found to have NAFLD at a 7-year follow-up. Baseline BMI, HOMA score, blood cholesterol, triglycerides, leptin levels, and weight gain (5.8±6.1 vs. 1.4±5.5kg, p<0.001) were significantly higher and adiponectin was lower among those who developed NAFLD at 7-year follow-up, compared with those who remained NAFLD-free. However, only weight gain and baseline HOMA were independent predictors for the development of NAFLD. Of the 66 patients who were found to have NAFLD at baseline, as many as 24 patients (36.4%) had no evidence of NAFLD at 7years. Weight loss of 2.7±5.0kg was significantly associated with NAFLD remission. Moreover, there was a 75% remission rate among NAFLD patients who lost 5% or more from their baseline weight.
CONCLUSIONS:
Among the general population, weight gain, and baseline insulin resistance are predictors for NAFLD incidence. One third of NAFLD patients may have remission of disease within a 7-year follow-up, mostly depending on modest weight reduction.
AuthorsShira Zelber-Sagi, Roni Lotan, Amir Shlomai, Muriel Webb, Gil Harrari, Assaf Buch, Dorit Nitzan Kaluski, Zamir Halpern, Ran Oren
JournalJournal of hepatology (J Hepatol) Vol. 56 Issue 5 Pg. 1145-1151 (May 2012) ISSN: 1600-0641 [Electronic] Netherlands
PMID22245895 (Publication Type: Journal Article)
CopyrightCopyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Topics
  • Adult
  • Aged
  • Fatty Liver (epidemiology, physiopathology, therapy)
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Insulin Resistance (physiology)
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease
  • Prospective Studies
  • Remission Induction
  • Risk Factors
  • Weight Gain (physiology)
  • Weight Loss (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: